By Linda Haymes
The Myeloma Center at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) is offering a new cutting-edge immunotherapy treatment for myeloma patients.
UAMS is the first and only medical facility in Arkansas approved to provide cellular therapy to myeloma patients.
“This is exciting because this is the first cellular therapy product commercially available for myeloma patients,” said Myeloma Center clinical director Frits van Rhee, M.D. Ph.D.
